Can Clinical Trials Requiring Frequent Participant Contact Be Conducted Over the Internet? Results From an Online Randomized Controlled Trial Evaluating a Topical Ointment for Herp...

by Formica, Margaret, Kabbara, Karim, Clark, Rachael, McAlindon, Tim
Published 2004

Tenascin Supports Lymphocyte Rolling

by Clark, Rachael A., Erickson, Harold P., Springer, Timothy A.
Published 1997

L-Selectin Ligands That Are O-glycoprotease Resistant and Distinct from MECA-79 Antigen are Sufficient for Tethering and Rolling of Lymphocytes on Human High Endothelial Venules

by Clark, Rachael A., Fuhlbrigge, Robert C., Springer, Timothy A.
Published 1998

Skin infection generates non-migratory memory CD8+ TRM cells providing global skin immunity

by Jiang, Xiaodong, Clark, Rachael A., Liu, Luzheng, Wagers, Amy J., Fuhlbrigge, Robert C., Kupper, Thomas S.
Published 2012

CD1a-autoreactive T cells are a normal component of the human αβ T cell repertoire

by de Jong, Annemieke, Peña-Cruz, Victor, Cheng, Tan-Yun, Clark, Rachael A., Van Rhijn, Ildiko, Moody, D. Branch
Published 2010

Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma

by Afanasiev, Olga K., Nagase, Kotaro, Simonson, William, Vandeven, Natalie, Blom, Astrid, Koelle, David M., Clark, Rachael, Nghiem, Paul
Published 2013

Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E- selectin expression in human squamous cell carcinomas

by Gehad, Ahmed, Lichtman, Michael, Schmults, Chrysalyne, Teague, Jessica E., Calarese, Adam, Jiang, Ying, Watanabe, Rei, Clark, Rachael A.
Published 2012

Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T cell exhaustion in reducing T cell responses

by Dowlatshahi, Mitra, Huang, Victor, Gehad, Ahmed, Jiang, Ying, Calarese, Adam, Teague, Jessica E., Dorosario, Andrew, Cheng, Jingwei, Nghiem, Paul, Schanbacher, Carl, Thakuria, Manisha, Schmults, Chrysalyne, Wang, Linda C., Clark, Rachael A.
Published 2013

Robust tumor immunity to melanoma mediated by interleukin 9

by Purwar, Rahul, Schlapbach, Christoph, Xiao, Sheng, Kang, Hong Soon, Elyaman, Wassim, Jiang, Xiaodong, Jetten, Anton M, Khoury, Samia J., Fuhlbrigge, Robert C, Kuchroo, Vijay K, Clark, Rachael A, Kupper, Thomas S
Published 2012

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine

by Mauldin, Ileana S, Wages, Nolan A, Stowman, Anne M, Wang, Ena, Smolkin, Mark E, Olson, Walter C, Deacon, Donna H, Smith, Kelly T, Galeassi, Nadejda, Teague, Jessica E, Clark, Rachael A, Marincola, Francesco M, Petroni, Gina R, Mullins, David W, Slingluff, Craig L
Published 2015